Baidu
map

眼科指南

订阅

MedSci主页 / 所有栏目 / 眼科指南

2016 中国角膜塑形用硬性透气性接触镜验配管理专家共识（2016年）

2016-05-30 国际角膜塑形学会亚洲分会 中华眼科杂志.2016,52(5):325-327.

硬性透气性接触镜

角膜塑形镜(orthokeratology lens)属于国家食品药品监督管理局认定的Ⅲ类医疗器械。国际角膜塑形学会亚洲分会中国区在中国女医师协会视光学专委会的协助下，在国内进行了调查研究，根据国内发展现状，参考国外的经验，在中华医学会眼科学分会眼视光学组2012年提出的《硬性透气性接触镜临床验配专家共识》的基础上，经过充分讨论形成了新的专家共识，旨在为角膜塑形镜的临床验配和管理提供进一步的指导性

中文标题：

2016 中国角膜塑形用硬性透气性接触镜验配管理专家共识（2016年）

发布机构：

国际角膜塑形学会亚洲分会

发布日期：

2016-05-30

简要介绍：

角膜塑形技术(orthokeratology)是通过配戴一系列特殊设计的几何形状与角膜前表面相逆的硬性透气性接触镜(rigid gas permeable contact lens，RGPCL)，镜片中央区平坦、旁中央区陡峭，以重塑角膜形态，使角膜中央区弧度在一定范同内出现平坦和规则样改变，从而暂时性降低近视屈光度数，提高裸眼视力的可逆性非手术物理矫形治疗方法，其同时可获得明显减缓近视眼发展的临床效果。
 
角膜塑形镜(orthokeratology lens)属于国家食品药品监督管理局认定的Ⅲ类医疗器械。国际角膜塑形学会亚洲分会中国区在中国女医师协会视光学专委会的协助下，在国内进行了调查研究，根据国内发展现状，参考国外的经验，在中华医学会眼科学分会眼视光学组2012年提出的《硬性透气性接触镜临床验配专家共识》的基础上，经过充分讨论形成了新的专家共识，旨在为角膜塑形镜的临床验配和管理提供进一步的指导性建议，从而进一步促进我国角膜塑形技术的健康发展。


角膜塑形镜的适应证和非适应证  

在一般接触镜适应证与非适应证的基础上，重点强调未成年儿童需要有家长监护配合治疗。年龄过小(<8岁)儿童如有特殊需求，由医师酌情考虑并增加对安全的监控，且需有家长理解和签署知情同意书。对于高屈光度数等疑难病例的验配，需由有丰富临床经验的医师酌情考虑验配。

角膜塑形镜的验配流程

(一)镜片选择  不同品牌的角膜塑形镜因材料、设计不同，有其特定的试戴片系统。试戴镜不宜通用，必须采用同类品种的试戴镜。若为日戴类型，则需要考虑镜片的精准屈光度数。

(二)验配程序  必须按照标准验配流程操作。建议参照国际角膜塑形学会亚洲分会编辑的《角膜塑形镜验配技术》等专业书籍中的规范程序。
 

相关资料下载：
[AttachmentFileName(sort=100, fileName=2016 中国角膜塑形用硬性透气性接触镜验配管理专家共识（2016年）)] GetToolGuiderByIdResponse(projectId=1, id=9d5b71c001251aec, title=2016 中国角膜塑形用硬性透气性接触镜验配管理专家共识（2016年）, enTitle=, guiderFrom=中华眼科杂志.2016,52(5):325-327., authorId=null, author=, summary=角膜塑形镜(orthokeratology lens)属于国家食品药品监督管理局认定的Ⅲ类医疗器械。国际角膜塑形学会亚洲分会中国区在中国女医师协会视光学专委会的协助下，在国内进行了调查研究，根据国内发展现状，参考国外的经验，在中华医学会眼科学分会眼视光学组2012年提出的《硬性透气性接触镜临床验配专家共识》的基础上，经过充分讨论形成了新的专家共识，旨在为角膜塑形镜的临床验配和管理提供进一步的指导性, cover=, journalId=null, articlesId=null, associationId=1231, associationName=国际角膜塑形学会亚洲分会, associationIntro=, copyright=0, guiderPublishedTime=Mon May 30 00:00:00 CST 2016, originalUrl=, linkOutUrl=, content=角膜塑形技术(orthokeratology)是通过配戴一系列特殊设计的几何形状与角膜前表面相逆的硬性透气性接触镜(rigid gas permeable contact lens，RGPCL)，镜片中央区平坦、旁中央区陡峭，以重塑角膜形态，使角膜中央区弧度在一定范同内出现平坦和规则样改变，从而暂时性降低近视屈光度数，提高裸眼视力的可逆性非手术物理矫形治疗方法，其同时可获得明显减缓近视眼发展的临床效果。<br>  <br> 角膜塑形镜(orthokeratology lens)属于国家食品药品监督管理局认定的Ⅲ类医疗器械。国际角膜塑形学会亚洲分会中国区在中国女医师协会视光学专委会的协助下，在国内进行了调查研究，根据国内发展现状，参考国外的经验，在中华医学会眼科学分会眼视光学组2012年提出的《硬性透气性接触镜临床验配专家共识》的基础上，经过充分讨论形成了新的专家共识，旨在为角膜塑形镜的临床验配和管理提供进一步的指导性建议，从而进一步促进我国角膜塑形技术的健康发展。<div><br></div><div><span style="font-weight: bold;">角膜塑形镜的适应证和非适应证  </span></div><div><br></div><div>在一般接触镜适应证与非适应证的基础上，重点强调未成年儿童需要有家长监护配合治疗。年龄过小(<8岁)儿童如有特殊需求，由医师酌情考虑并增加对安全的监控，且需有家长理解和签署知情同意书。对于高屈光度数等疑难病例的验配，需由有丰富临床经验的医师酌情考虑验配。</div><div><br></div><div><span style="font-weight: bold;">角膜塑形镜的验配流程</span></div><div><span style="font-weight: bold;"><br></span></div><div>(一)镜片选择  不同品牌的角膜塑形镜因材料、设计不同，有其特定的试戴片系统。试戴镜不宜通用，必须采用同类品种的试戴镜。若为日戴类型，则需要考虑镜片的精准屈光度数。</div><div><br></div><div>(二)验配程序  必须按照标准验配流程操作。建议参照国际角膜塑形学会亚洲分会编辑的《角膜塑形镜验配技术》等专业书籍中的规范程序。<br>  <div><br> </div> <div><div>拓展指南：<strong>与<font color="red">硬性透气性接触镜</font>相关指南：</strong><br><ul><li><a href="//m.capotfarm.com/guideline/show_article.do?id=9f29a1c001251542" title="2012 硬性透气性接触镜临床验配专家共识（2012年）" target="_blank">2012 硬性透气性接触镜临床验配专家共识（2012年）</a></li> <li><a href="//m.capotfarm.com/guideline/show_article.do?id=9d5b71c001251aec" title="2016 中国角膜塑形用硬性透气性接触镜验配管理专家共识（2016年）" target="_blank">2016 中国角膜塑形用硬性透气性接触镜验配管理专家共识（2016年）</a></li> <li><a href="//m.capotfarm.com/guideline/show_article.do?id=d38fb1c00090623c" title="硬性透气性接触镜临床验配专家共识（2012年）" target="_blank">硬性透气性接触镜临床验配专家共识（2012年）</a></li> 更多信息请点击：<a href="//m.capotfarm.com/guideline/list.do?q=%E7%A1%AC%E6%80%A7%E9%80%8F%E6%B0%94%E6%80%A7%E6%8E%A5%E8%A7%A6%E9%95%9C" target="_blank">有关硬性透气性接触镜更多指南</a></ul></div></div></div>, tagList=[TagDto(tagId=37153, tagName=硬性透气性接触镜)], categoryList=[CategoryDto(categoryId=32, categoryName=眼科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=3, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=12076, appHits=151, showAppHits=0, pcHits=6729, showPcHits=6689, likes=163, shares=4, comments=7, approvalStatus=1, publishedTime=Mon Aug 08 11:11:22 CST 2016, publishedTimeString=2016-05-30, pcVisible=1, appVisible=1, editorId=5295957, editor=lili, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=lili, createdTime=Mon Aug 08 11:11:22 CST 2016, updatedBy=null, updatedName=null, updatedTime=Tue Jan 02 04:21:31 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2016 中国角膜塑形用硬性透气性接触镜验配管理专家共识（2016年）)])
2016 中国角膜塑形用硬性透气性接触镜验配管理专家共识（2016年）
下载请点击：
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2207877, encodeId=ce46220e877ee, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35a76467318, createdName=ms1000000571410828, createdTime=Sun Jun 02 00:26:59 CST 2024, time=2024-06-02, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=910073, encodeId=627e9100e362, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200818/880c1c6388a746ba9d119bfcdc861297/62661b3226e441b08d535541976faa6a.jpg, createdBy=d42d2088603, createdName=MaYazhen, createdTime=Tue Dec 22 13:43:28 CST 2020, time=2020-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=101696, encodeId=7f9710169632, content=继续学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Sat Aug 20 17:55:00 CST 2016, time=2016-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=101697, encodeId=89ec10169e25, content=继续关注, beContent=null, objectType=guider, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Sat Aug 20 17:55:00 CST 2016, time=2016-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=101693, encodeId=b3a6101693c2, content=继续学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Sat Aug 20 17:53:00 CST 2016, time=2016-08-20, status=1, ipAttribution=)]
    2024-06-02 ms1000000571410828 来自安徽省

    学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2207877, encodeId=ce46220e877ee, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35a76467318, createdName=ms1000000571410828, createdTime=Sun Jun 02 00:26:59 CST 2024, time=2024-06-02, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=910073, encodeId=627e9100e362, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200818/880c1c6388a746ba9d119bfcdc861297/62661b3226e441b08d535541976faa6a.jpg, createdBy=d42d2088603, createdName=MaYazhen, createdTime=Tue Dec 22 13:43:28 CST 2020, time=2020-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=101696, encodeId=7f9710169632, content=继续学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Sat Aug 20 17:55:00 CST 2016, time=2016-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=101697, encodeId=89ec10169e25, content=继续关注, beContent=null, objectType=guider, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Sat Aug 20 17:55:00 CST 2016, time=2016-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=101693, encodeId=b3a6101693c2, content=继续学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Sat Aug 20 17:53:00 CST 2016, time=2016-08-20, status=1, ipAttribution=)]
    2020-12-22 MaYazhen

    学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2207877, encodeId=ce46220e877ee, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35a76467318, createdName=ms1000000571410828, createdTime=Sun Jun 02 00:26:59 CST 2024, time=2024-06-02, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=910073, encodeId=627e9100e362, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200818/880c1c6388a746ba9d119bfcdc861297/62661b3226e441b08d535541976faa6a.jpg, createdBy=d42d2088603, createdName=MaYazhen, createdTime=Tue Dec 22 13:43:28 CST 2020, time=2020-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=101696, encodeId=7f9710169632, content=继续学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Sat Aug 20 17:55:00 CST 2016, time=2016-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=101697, encodeId=89ec10169e25, content=继续关注, beContent=null, objectType=guider, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Sat Aug 20 17:55:00 CST 2016, time=2016-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=101693, encodeId=b3a6101693c2, content=继续学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Sat Aug 20 17:53:00 CST 2016, time=2016-08-20, status=1, ipAttribution=)]
    2016-08-20 doctorJiangchao

    继续学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2207877, encodeId=ce46220e877ee, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35a76467318, createdName=ms1000000571410828, createdTime=Sun Jun 02 00:26:59 CST 2024, time=2024-06-02, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=910073, encodeId=627e9100e362, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200818/880c1c6388a746ba9d119bfcdc861297/62661b3226e441b08d535541976faa6a.jpg, createdBy=d42d2088603, createdName=MaYazhen, createdTime=Tue Dec 22 13:43:28 CST 2020, time=2020-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=101696, encodeId=7f9710169632, content=继续学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Sat Aug 20 17:55:00 CST 2016, time=2016-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=101697, encodeId=89ec10169e25, content=继续关注, beContent=null, objectType=guider, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Sat Aug 20 17:55:00 CST 2016, time=2016-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=101693, encodeId=b3a6101693c2, content=继续学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Sat Aug 20 17:53:00 CST 2016, time=2016-08-20, status=1, ipAttribution=)]
    2016-08-20 doctorJiangchao

    继续关注

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2207877, encodeId=ce46220e877ee, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35a76467318, createdName=ms1000000571410828, createdTime=Sun Jun 02 00:26:59 CST 2024, time=2024-06-02, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=910073, encodeId=627e9100e362, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200818/880c1c6388a746ba9d119bfcdc861297/62661b3226e441b08d535541976faa6a.jpg, createdBy=d42d2088603, createdName=MaYazhen, createdTime=Tue Dec 22 13:43:28 CST 2020, time=2020-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=101696, encodeId=7f9710169632, content=继续学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Sat Aug 20 17:55:00 CST 2016, time=2016-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=101697, encodeId=89ec10169e25, content=继续关注, beContent=null, objectType=guider, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Sat Aug 20 17:55:00 CST 2016, time=2016-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=101693, encodeId=b3a6101693c2, content=继续学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Sat Aug 20 17:53:00 CST 2016, time=2016-08-20, status=1, ipAttribution=)]
    2016-08-20 doctorJiangchao

    继续学习

    0

Baidu
map
Baidu
map
Baidu
map